vs

Side-by-side financial comparison of CVRx, Inc. (CVRX) and Digimarc CORP (DMRC). Click either name above to swap in a different company.

CVRx, Inc. is the larger business by last-quarter revenue ($16.0M vs $8.9M, roughly 1.8× Digimarc CORP). Digimarc CORP runs the higher net margin — -47.2% vs -74.5%, a 27.2% gap on every dollar of revenue. On growth, CVRx, Inc. posted the faster year-over-year revenue change (4.4% vs 2.9%). Digimarc CORP produced more free cash flow last quarter ($895.0K vs $-9.8M). Over the past eight quarters, CVRx, Inc.'s revenue compounded faster (22.0% CAGR vs -5.3%).

CVRx, Inc. is a commercial-stage medical technology company specializing in neuromodulation therapies for chronic cardiovascular diseases. Its flagship Barostim system treats heart failure and resistant hypertension, with core markets across North America and Europe, serving patients unresponsive to conventional drug treatments.

Digimarc Corporation is a provider of enterprise software and services. The company's software, which includes digital identifiers, is designed to address counterfeiting, product authenticity, recycling accuracy, and supply chain traceability. Digimarc products are created for multiple industries such as apparel, consumer packaged goods, health and beauty, and automotive.

CVRX vs DMRC — Head-to-Head

Bigger by revenue
CVRX
CVRX
1.8× larger
CVRX
$16.0M
$8.9M
DMRC
Growing faster (revenue YoY)
CVRX
CVRX
+1.6% gap
CVRX
4.4%
2.9%
DMRC
Higher net margin
DMRC
DMRC
27.2% more per $
DMRC
-47.2%
-74.5%
CVRX
More free cash flow
DMRC
DMRC
$10.7M more FCF
DMRC
$895.0K
$-9.8M
CVRX
Faster 2-yr revenue CAGR
CVRX
CVRX
Annualised
CVRX
22.0%
-5.3%
DMRC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CVRX
CVRX
DMRC
DMRC
Revenue
$16.0M
$8.9M
Net Profit
$-11.9M
$-4.2M
Gross Margin
86.3%
63.5%
Operating Margin
-69.8%
-48.2%
Net Margin
-74.5%
-47.2%
Revenue YoY
4.4%
2.9%
Net Profit YoY
-12.0%
51.4%
EPS (diluted)
$-0.45
$-0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVRX
CVRX
DMRC
DMRC
Q4 25
$16.0M
$8.9M
Q3 25
$14.7M
$7.6M
Q2 25
$13.6M
$8.0M
Q1 25
$12.3M
$9.4M
Q4 24
$15.3M
$8.7M
Q3 24
$13.4M
$9.4M
Q2 24
$11.8M
$10.4M
Q1 24
$10.8M
$9.9M
Net Profit
CVRX
CVRX
DMRC
DMRC
Q4 25
$-11.9M
$-4.2M
Q3 25
$-12.9M
$-8.2M
Q2 25
$-14.7M
$-8.2M
Q1 25
$-13.8M
$-11.7M
Q4 24
$-10.7M
$-8.6M
Q3 24
$-13.1M
$-10.8M
Q2 24
$-14.0M
$-9.3M
Q1 24
$-22.2M
$-10.3M
Gross Margin
CVRX
CVRX
DMRC
DMRC
Q4 25
86.3%
63.5%
Q3 25
86.8%
58.3%
Q2 25
84.3%
58.8%
Q1 25
83.5%
65.0%
Q4 24
83.2%
60.8%
Q3 24
83.2%
62.4%
Q2 24
83.9%
66.1%
Q1 24
85.0%
62.5%
Operating Margin
CVRX
CVRX
DMRC
DMRC
Q4 25
-69.8%
-48.2%
Q3 25
-83.5%
-109.7%
Q2 25
-105.8%
-105.2%
Q1 25
-108.8%
-128.9%
Q4 24
-67.0%
-105.1%
Q3 24
-97.3%
-120.4%
Q2 24
-118.3%
-96.2%
Q1 24
-206.4%
-109.2%
Net Margin
CVRX
CVRX
DMRC
DMRC
Q4 25
-74.5%
-47.2%
Q3 25
-87.6%
-106.9%
Q2 25
-108.4%
-102.6%
Q1 25
-111.5%
-125.2%
Q4 24
-69.4%
-99.9%
Q3 24
-98.0%
-113.9%
Q2 24
-118.8%
-89.3%
Q1 24
-206.0%
-104.0%
EPS (diluted)
CVRX
CVRX
DMRC
DMRC
Q4 25
$-0.45
$-0.18
Q3 25
$-0.49
$-0.38
Q2 25
$-0.57
$-0.38
Q1 25
$-0.53
$-0.55
Q4 24
$-0.39
$-0.40
Q3 24
$-0.57
$-0.50
Q2 24
$-0.65
$-0.43
Q1 24
$-1.04
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVRX
CVRX
DMRC
DMRC
Cash + ST InvestmentsLiquidity on hand
$75.7M
$12.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$39.3M
$40.2M
Total Assets
$104.8M
$53.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVRX
CVRX
DMRC
DMRC
Q4 25
$75.7M
$12.9M
Q3 25
$85.1M
$12.6M
Q2 25
$95.0M
$16.1M
Q1 25
$102.7M
$21.6M
Q4 24
$105.9M
$28.7M
Q3 24
$100.2M
$33.7M
Q2 24
$70.4M
$41.5M
Q1 24
$80.1M
$48.9M
Stockholders' Equity
CVRX
CVRX
DMRC
DMRC
Q4 25
$39.3M
$40.2M
Q3 25
$48.1M
$41.4M
Q2 25
$57.9M
$46.5M
Q1 25
$71.1M
$50.0M
Q4 24
$71.1M
$61.4M
Q3 24
$65.2M
$70.2M
Q2 24
$55.2M
$77.2M
Q1 24
$66.3M
$84.5M
Total Assets
CVRX
CVRX
DMRC
DMRC
Q4 25
$104.8M
$53.0M
Q3 25
$111.3M
$55.4M
Q2 25
$119.6M
$60.7M
Q1 25
$129.6M
$66.5M
Q4 24
$133.4M
$75.8M
Q3 24
$127.7M
$85.0M
Q2 24
$96.0M
$93.4M
Q1 24
$106.2M
$99.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVRX
CVRX
DMRC
DMRC
Operating Cash FlowLast quarter
$-9.8M
$991.0K
Free Cash FlowOCF − Capex
$-9.8M
$895.0K
FCF MarginFCF / Revenue
-61.3%
10.0%
Capex IntensityCapex / Revenue
0.4%
1.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-40.8M
$-12.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVRX
CVRX
DMRC
DMRC
Q4 25
$-9.8M
$991.0K
Q3 25
$-9.7M
$-2.6M
Q2 25
$-7.9M
$-4.7M
Q1 25
$-12.8M
$-5.5M
Q4 24
$-8.0M
$-4.2M
Q3 24
$-10.4M
$-7.1M
Q2 24
$-9.8M
$-6.8M
Q1 24
$-10.9M
$-8.4M
Free Cash Flow
CVRX
CVRX
DMRC
DMRC
Q4 25
$-9.8M
$895.0K
Q3 25
$-10.0M
$-2.8M
Q2 25
$-8.0M
$-4.9M
Q1 25
$-12.9M
$-5.5M
Q4 24
$-8.1M
$-4.2M
Q3 24
$-10.4M
$-7.2M
Q2 24
$-10.2M
$-6.9M
Q1 24
$-11.8M
$-8.5M
FCF Margin
CVRX
CVRX
DMRC
DMRC
Q4 25
-61.3%
10.0%
Q3 25
-68.1%
-36.9%
Q2 25
-59.2%
-61.0%
Q1 25
-104.3%
-59.1%
Q4 24
-52.5%
-49.1%
Q3 24
-78.1%
-75.7%
Q2 24
-86.3%
-66.1%
Q1 24
-109.7%
-85.8%
Capex Intensity
CVRX
CVRX
DMRC
DMRC
Q4 25
0.4%
1.1%
Q3 25
2.0%
2.9%
Q2 25
0.8%
2.5%
Q1 25
0.9%
0.6%
Q4 24
0.3%
0.2%
Q3 24
0.3%
0.7%
Q2 24
3.0%
0.3%
Q1 24
8.5%
1.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVRX
CVRX

US$14.9M93%
Other$1.1M7%

DMRC
DMRC

Subscription$5.3M60%
The Government$3.6M41%

Related Comparisons